Cargando…

IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations

BACKGROUND: Although there are various international consensus recommendations on the use of botulinum neurotoxin type A (BoNT/A) in facial aesthetics, there are no global or Russian guidelines on the optimal dose of incobotulinumtoxinA, free from complexing proteins, within specific aesthetic indic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yutskovskaya, Yana, Gubanova, Elena, Khrustaleva, Irina, Atamanov, Vasiliy, Saybel, Anastasiya, Parsagashvili, Elena, Dmitrieva, Irina, Sanchez, Elena, Lapatina, Natalia, Korolkova, Tatiana, Saromytskaya, Alena, Goltsova, Elena, Satardinova, Elmira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467658/
https://www.ncbi.nlm.nih.gov/pubmed/26089695
http://dx.doi.org/10.2147/CCID.S72301
_version_ 1782376396967903232
author Yutskovskaya, Yana
Gubanova, Elena
Khrustaleva, Irina
Atamanov, Vasiliy
Saybel, Anastasiya
Parsagashvili, Elena
Dmitrieva, Irina
Sanchez, Elena
Lapatina, Natalia
Korolkova, Tatiana
Saromytskaya, Alena
Goltsova, Elena
Satardinova, Elmira
author_facet Yutskovskaya, Yana
Gubanova, Elena
Khrustaleva, Irina
Atamanov, Vasiliy
Saybel, Anastasiya
Parsagashvili, Elena
Dmitrieva, Irina
Sanchez, Elena
Lapatina, Natalia
Korolkova, Tatiana
Saromytskaya, Alena
Goltsova, Elena
Satardinova, Elmira
author_sort Yutskovskaya, Yana
collection PubMed
description BACKGROUND: Although there are various international consensus recommendations on the use of botulinum neurotoxin type A (BoNT/A) in facial aesthetics, there are no global or Russian guidelines on the optimal dose of incobotulinumtoxinA, free from complexing proteins, within specific aesthetic indications. This article reports the outcomes of two expert consensus meetings, conducted to review and analyze efficacy and tolerability data for incobotulinumtoxinA in various facial aesthetic indications and to give expert consensus recommendations to ensure best clinical practice among Russian clinicians. METHODS: Thirteen dermatology and/or plastic surgery experts attended meetings held in Paris, France (November 2013), and Moscow, Russia (March 2014). The expert group reviewed and analyzed the existing evidence, consensus recommendations, and Russian experts’ extensive practical experience of incobotulinumtoxinA in aesthetics to reach consensus on optimal doses, potential dose adjustments, and injection sites of incobotulinumtoxinA for facial aesthetics. RESULTS: All experts developed guidance on the optimal doses for incobotulinumtoxinA treatment of different regions of the upper and lower face. The expert panel agreed that there are no differences in the efficacy and duration of the effect between the four BoNT/As that are commercially available for facial aesthetic indications in Russia and that, when administered correctly, all BoNT/As can achieve optimal results. Experts also agreed that nonresponse to BoNT/A can be caused by neutralizing antibodies. CONCLUSION: On the basis of the scientific and clinical evidence available for incobotulinumtoxinA, coupled with the extensive clinical experience of the consensus group, experts recommended the optimal doses of incobotulinumtoxinA effective for treatment of wrinkles of the upper and lower face to achieve the expected aesthetic outcome. These first Russian guidelines on the optimal use of incobotulinumtoxinA for augmentation of glabellar lines, periorbital wrinkles, forehead lines, bunny lines, perioral wrinkles, depressor anguli oris, mentalis, masseters and platysmal bands, and performing the Nefertiti lift, are presented here.
format Online
Article
Text
id pubmed-4467658
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-44676582015-06-18 IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations Yutskovskaya, Yana Gubanova, Elena Khrustaleva, Irina Atamanov, Vasiliy Saybel, Anastasiya Parsagashvili, Elena Dmitrieva, Irina Sanchez, Elena Lapatina, Natalia Korolkova, Tatiana Saromytskaya, Alena Goltsova, Elena Satardinova, Elmira Clin Cosmet Investig Dermatol Expert Opinion BACKGROUND: Although there are various international consensus recommendations on the use of botulinum neurotoxin type A (BoNT/A) in facial aesthetics, there are no global or Russian guidelines on the optimal dose of incobotulinumtoxinA, free from complexing proteins, within specific aesthetic indications. This article reports the outcomes of two expert consensus meetings, conducted to review and analyze efficacy and tolerability data for incobotulinumtoxinA in various facial aesthetic indications and to give expert consensus recommendations to ensure best clinical practice among Russian clinicians. METHODS: Thirteen dermatology and/or plastic surgery experts attended meetings held in Paris, France (November 2013), and Moscow, Russia (March 2014). The expert group reviewed and analyzed the existing evidence, consensus recommendations, and Russian experts’ extensive practical experience of incobotulinumtoxinA in aesthetics to reach consensus on optimal doses, potential dose adjustments, and injection sites of incobotulinumtoxinA for facial aesthetics. RESULTS: All experts developed guidance on the optimal doses for incobotulinumtoxinA treatment of different regions of the upper and lower face. The expert panel agreed that there are no differences in the efficacy and duration of the effect between the four BoNT/As that are commercially available for facial aesthetic indications in Russia and that, when administered correctly, all BoNT/As can achieve optimal results. Experts also agreed that nonresponse to BoNT/A can be caused by neutralizing antibodies. CONCLUSION: On the basis of the scientific and clinical evidence available for incobotulinumtoxinA, coupled with the extensive clinical experience of the consensus group, experts recommended the optimal doses of incobotulinumtoxinA effective for treatment of wrinkles of the upper and lower face to achieve the expected aesthetic outcome. These first Russian guidelines on the optimal use of incobotulinumtoxinA for augmentation of glabellar lines, periorbital wrinkles, forehead lines, bunny lines, perioral wrinkles, depressor anguli oris, mentalis, masseters and platysmal bands, and performing the Nefertiti lift, are presented here. Dove Medical Press 2015-06-05 /pmc/articles/PMC4467658/ /pubmed/26089695 http://dx.doi.org/10.2147/CCID.S72301 Text en © 2015 Yutskovskaya et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Expert Opinion
Yutskovskaya, Yana
Gubanova, Elena
Khrustaleva, Irina
Atamanov, Vasiliy
Saybel, Anastasiya
Parsagashvili, Elena
Dmitrieva, Irina
Sanchez, Elena
Lapatina, Natalia
Korolkova, Tatiana
Saromytskaya, Alena
Goltsova, Elena
Satardinova, Elmira
IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
title IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
title_full IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
title_fullStr IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
title_full_unstemmed IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
title_short IncobotulinumtoxinA in aesthetics: Russian multidisciplinary expert consensus recommendations
title_sort incobotulinumtoxina in aesthetics: russian multidisciplinary expert consensus recommendations
topic Expert Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467658/
https://www.ncbi.nlm.nih.gov/pubmed/26089695
http://dx.doi.org/10.2147/CCID.S72301
work_keys_str_mv AT yutskovskayayana incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT gubanovaelena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT khrustalevairina incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT atamanovvasiliy incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT saybelanastasiya incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT parsagashvilielena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT dmitrievairina incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT sanchezelena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT lapatinanatalia incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT korolkovatatiana incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT saromytskayaalena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT goltsovaelena incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations
AT satardinovaelmira incobotulinumtoxinainaestheticsrussianmultidisciplinaryexpertconsensusrecommendations